TauRx Announces Results from Phase 3 Alzheimer's Disease Study...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
ABERDEEN, Scotland and SINGAPORE, Oct. 6, 2022 /PRNewswire-AsiaNet/ -- - For people with early Alzheimer's (MCI), HMTM treatment resulted in sustained improvement in cognition over pre-treatment baseline, and normalisation of brain atrophy to a rate similar to healthy individuals- For people with mild to moderate A...
Authors: LATEST ASIANET NEWS RELEASES